Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun:63:264-268.
doi: 10.1016/j.jcrc.2021.01.009. Epub 2021 Jan 30.

Cheap and simple, could it get even cooler? Mild hypothermia and COVID-19

Raul Dos Reis Ururahy  1 , Marcelo Park  2
Affiliations

Cheap and simple, could it get even cooler? Mild hypothermia and COVID-19

Raul Dos Reis Ururahy et al. J Crit Care. 2021 Jun.

Abstract

Purpose: The pathophysiology theories of COVID-19 attach the injury of target organs to faulty immune responses and occasionally hyper-inflammation. The damage frequently extends beyond the respiratory system, accompanying cardiovascular, renal, central nervous system, and/or coagulation derangements. Tumor necrosis factor-α (TNF-α) and interleukins (IL)-1 and - 6 suppression may improve outcomes, as experimentally shown. Targeted therapies have been proposed, but mild therapeutic hypothermia-a more multifaceted approach-could be suitable.

Findings: According to evidence derived from previous applications, therapeutic hypothermia diminishes the release of IL-1, IL-6, and TNF-α in serum and at the tissue level. PaCO2 is reduced and the PaO2/FiO2 ratio is increased, possibly lasting after rewarming. Cooling might mitigate both ventilator and infectious-induced lung injury, and suppress microthrombi development, enhancing V/Q mismatch. Improvements in microhemodynamics and tissue O2 diffusion, along with the ischemia-tolerance heightening of tissues, could be reached. Arrhythmia incidence diminishes. Moreover, hypothermia may address the coagulopathy, promoting normalization of both hypo- and hyper-coagulability patterns, which are apparently sustained after a return to normothermia.

Conclusions: As per prior therapeutic hypothermia literature, the benefits regarding inflammatory response and organic damage might be seen. Following the safety-cornerstones of the technique, the overall infection rate and infection-related mortality are not expected to rise, and increased viral replication does not seem to be a concern. Therefore, the possibility of a low cost and widely available therapy being capable of improving COVID-19 outcomes deserves further study.

Keywords: COVID-19; Cooling; Cytokine storm; Mild therapeutic hypothermia; SARS CoV2.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Jamilloux Y., Henry T., Belot A., Viel S., Fauter M., Jammal T.E., et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19(7):102567. doi: 10.1016/j.autrev.2020.102567. [Epub 2020 May 4] - DOI - PMC - PubMed
    1. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S0140-6736(20)30628-0. - DOI - PMC - PubMed
    1. Yokota S., Imagawa T., Miyamae T., Ito S.-I., Nakajima S., Nezu A., et al. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int. 2000;42(2):197–203. doi: 10.1046/j.1442-200x.2000.01204.x. - DOI - PubMed
    1. Johansen M.E., Jensen J.U., Bestle M.H., Ostrowski S.R., Thormar K., Christensen H., et al. Mild induced hypothermia: effects on sepsis-related coagulopathy—results from a randomized controlled trial. Thromb Res. 2015;135(1):175–182. doi: 10.1016/j.thromres.2014.10.028. - DOI - PubMed
    1. Polderman K.H. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009 Jul;37(Suppl. 7):S186–S202. doi: 10.1097/ccm.0b013e3181aa5241. - DOI - PubMed